RNA, U6 small nuclear 189, pseudogene (RNU6-189P)

RNU6-189P is classified as a pseudogene, derived from the U6 small nuclear RNA gene family[2]. While the canonical U6 snRNA is a vital part of the spliceosome machinery, necessary for intron removal in pre-mRNA and conserved throughout evolution[1][3], RNU6-189P itself is a non-functional copy. Pseudogenes like RNU6-189P typically do not produce active RNA or protein products; instead, they are remnants of ancestral gene duplication or retrotransposition events. Most are biologically inert—although, in rare cases, pseudogenes can be transcribed and influence regulatory networks, there is no evidence that RNU6-189P does so[2][6]. RNU6-189P is not considered a direct therapeutic or research target. Summary of structure and biological context: - The canonical U6 snRNA mediates pre-mRNA splicing in eukaryotes and is essential for spliceosome function, displaying high conservation and structural complexity[1][3]. - U6-derived pseudogenes (such as RNU6-189P) are abundant in vertebrate genomes; their presence likely reflects evolutionary redundancy but does not imply functional significance for each individual pseudogene[1][2]. - While some pseudogenes can play roles in gene regulation, competitive endogenous RNA networks, or as disease modulators, no evidence specific to RNU6-189P supports such roles[6]. Note: This entry describes a pseudogene, which by conventional nomenclature and biological function, is not a receptor, enzyme, transporter, transcription factor, or similar molecular therapeutic target. Thus, RNU6-189P should not be considered a valid target for structured drug or biomarker curation[2][6].

Other names

RNU6-189PU6 small nuclear RNA 189 pseudogeneRNA, U6 small nuclear 189, pseudogene

null